Brink A J, Bizos D, Boffard K D, Feldman C, Grolman D C, Pretorius J, Richards G A, Steyn E
Ampath National Laboratory Services, Milpark Hospital, Johannesburg.
S Afr J Surg. 2012 Feb 14;50(1):20-1.
Tigecycline, the first of a new class of broad-spectrum antibiotics (the glycylcyclines), has been licensed in South Africa for the parenteral treatment of adult patients with complicated intra-abdominal infections (cIAIs) and complicated skin and soft-tissue infections (cSSTIs). This article serves as a summary of the guideline on the appropriate use of tigecycline, published in mid-2010 as a collaborative effort by representatives of the Association of Surgeons of South Africa, the Critical Care Society of Southern Africa, the Federation of Infectious Diseases Societies of Southern Africa, the South African Thoracic Society and the Trauma Society of South Africa.
替加环素是新型广谱抗生素（甘氨酰环素类）中的首个药物，已在南非获批用于成人复杂性腹腔内感染（cIAIs）和复杂性皮肤及软组织感染（cSSTIs）的肠外治疗。本文是关于替加环素合理使用指南的总结，该指南于2010年年中由南非外科医生协会、南部非洲危重症医学会、南部非洲传染病学会联合会、南非胸科学会和南非创伤学会的代表共同发布。
